Seeking Alpha

Covidien (COV) announces it purchased privately-held Barrx Medical in a $325M deal expected to...

Covidien (COV) announces it purchased privately-held Barrx Medical in a $325M deal expected to close in Q1. The firm says the acquisition will help expand its ability to treat gastrointestinal diseases, such as Barrett’s esophagus.
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Tools
Find the right ETFs for your portfolio:
Seeking Alpha's new ETF Hub
ETF Investment Guide:
Table of Contents | One Page Summary
Read about different ETF Asset Classes:
ETF Selector

Next headline on your portfolio:

|